Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock Stage.
Ivan D HansonAkash RusiaAndres PalomoAdam TawneyTimothy PowSimon R DixonPerwaiz M MerajEric SieversMichael JohnsonDavid H W WohnsOmar AliNavin K KapurCindy L GrinesDaniel BurkhoffMark AndersonAlexandra LanskySrihari S NaiduMir Babar BasirWilliam W O'NeillPublished in: Journal of the American Heart Association (2024)
In a real-world cohort of patients with acute myocardial infarction with cardiogenic shock undergoing percutaneous coronary intervention with Impella support, only stage E classification at ≤24 hours was significantly predictive of mortality, suggesting that response to therapy may be more important than clinical severity of shock at presentation.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- acute coronary syndrome
- antiplatelet therapy
- left ventricular
- coronary artery bypass grafting
- optical coherence tomography
- machine learning
- cardiovascular events
- computed tomography
- deep learning
- physical activity
- extracorporeal membrane oxygenation
- atrial fibrillation
- coronary artery bypass
- type diabetes
- stem cells
- mesenchymal stem cells
- skeletal muscle
- bone marrow
- smoking cessation